[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349850-105":59,"doc-detail-349850-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","multi-omics-characterization-of-rna-modification-enzymes-identifies-nat10-as-a-functionally-validated-prognostic-biomarker-in-hepatocellular-carcinoma","Multi-omics characterization of RNA modification enzymes identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma","","RNA modification enzymes (RMEs) act as key post-transcriptional regulators influencing RNA stability, translation, and splicing, and their dysregulation is linked to tumor initiation and progression. Using integrative multi-omics across multiple cancers, the study analyzes RME expression, copy number variation, and clinical outcomes, builds and validates machine-learning prognostic signatures, and applies single-cell transcriptomics to characterize tumor microenvironment heterogeneity. NAT10 knockdown reduces HCC proliferation and supports an RNAs-modification framework for cancer stratification.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-characterization-of-rna-modification-enzymes-identifies-nat10-as-a-functionally-validated-prognostic-biomarker-in-hepatocellular-carcinoma/349850/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-characterization-of-rna-modification-enzymes-identifies-nat10-as-a-functionally-validated-prognostic-biomarker-in-hepatocellular-carcinoma/349850.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal?","Question",{"text":112,"@type":113},"The study characterizes RNA modification enzymes using integrative multi-omics and identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were prognostic and diagnostic models developed and validated?",{"text":117,"@type":113},"A LASSO-derived prognostic model was trained and validated in independent cohorts, and the work integrates a 6-gene prognostic model into a calibrated nomogram.",{"name":119,"@type":110,"acceptedAnswer":120},"What did single-cell analyses reveal about the selected RMEs?",{"text":121,"@type":113},"Single-cell transcriptomic analysis showed that most selected RMEs, including NAT10, are enriched in tumor-infiltrating cells, and specific T-cell subpopulations display distinct RME expression patterns.",{"name":123,"@type":110,"acceptedAnswer":124},"What functional evidence supports NAT10 in hepatocellular carcinoma?",{"text":125,"@type":113},"NAT10 knockdown in HCC cells reduced proliferative activity validated by qRT-PCR and EdU assays, and immunohistochemistry supported NAT10 overexpression in clinical tumor specimens versus adjacent normal tissues.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},349850,1790617654,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":31,"preview_page_count":19,"preview_urls":148},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 28 January 2026  \nDOI 10.3389/fimmu.2026.1764106  \nOPEN ACCESS  \nEDITED BY  \nWei-jia Wang,  \nFujian Medical University, China  \nREVIEWED BY  \nSijie Chen,  \nStanford University, United States Xu Cheng,  \nAnqing Normal University, China  \n*CORRESPONDENCE  \nXiangting Wang  \n [wangxt11@ustc.edu.cn](wangxt11@ustc.edu.cn)[ ](wangxt11@ustc.edu.cn)Xiaolin Liang  \n [LXL9209@ustc.edu.cn](LXL9209@ustc.edu.cn)  \nRECEIVED 09 December 2025  \nREVISED 07 January 2026  \nACCEPTED 12 January 2026  \nPUBLISHED 28 January 2026  \nCITATION  \nZhan Q, Sun H, Wang X and Liang X (2026) Multi-omics characterization of RNA modiﬁcation enzymes identiﬁes NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma.  \nFront. Immunol. 17:1764106 .  \ndoi: 10.3389/fimmu.2026.1764106  \nCOPYRIGHT  \n© 2026 Zhan, Sun, Wang and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMulti-omics characterization of RNA modiﬁcation enzymesidentiﬁes NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma  \nQianqian Zhan 1,2,3, Huihui Sun 2,3, Xiangting Wang 2,3* and Xiaolin Liang 2,3*  \n1 Division of Life Sciences and Medicine, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, China, 2 Department of Geriatrics, Gerontology Institute of Anhui Province, Centre for Leading Medicine and Advanced Technologies of IHM, The First Afﬁliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China, 3Anhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Hefei, Anhui, China  \nBackground: RNA modiﬁcation enzymes (RMEs) are key post-transcriptional regulators that impact RNA stability, translation, and splicing. Dysregulation of RMEs is closely associated with tumor initiation and progression. However, their global regulatory patterns and clinical relevance across cancer types remain incompletely characterized.  \nMethods: We conducted an integrative multi-omics analysis of RME expression, copy number variation (CNV), and clinical outcomes across multiple cancers. Machine learning algorithms were employed to identify tumor-discriminating RME signatures. Single-cell RNA sequencing (scRNA-seq) characterized tumor microenvironmental heterogeneity. A LASSO-derived prognostic model was established and validated in independent cohorts. Drug sensitivity prediction and supportive functional assays (EdU assays, qRT-PCR, immunohistochemistry) were performed for representative RMEs.  \nResults: RMEs were broadly upregulated across cancers and showed strong associations with CNV gains. Machine learning identiﬁed 12 RMEs that reliably discriminated tumor from normal tissues. Single-cell transcriptomic analysis showed that 10 of the 12 selected RMEs (DKC1, METTL1, NAT10, TRMT1, RPUSD1, PUS1, WDR4, TRMU, ADAT2, GTPBP3) exhibited higher expression in tumor-inﬁltrating cells compared with adjacent normal tissues. T-cell subpopulations displayed marked heterogeneity, with ADAT2 preferentially enriched in regulatory T cells. CellChat analysis revealed T cell subsets as key mediators of intercellular communication via multiple immune-related pathways . A 6-gene prognostic model exhibited independent prognostic power and was integrated into a well-calibrated nomogram. Drug-response prediction revealed that high-risk patients exhibited enhanced sensitivity to microtubule-targeting agents and kinase inhibitors, whereas low-risk patients showed preferential response to epigenetic modulators. Importantly, sup","cbCaiqKalbZIwB2D","https://ap.wps.com/l/cbCaiqKalbZIwB2D","pdf",29336997,"English","# Background\n# Methods\n## Integrative multi-omics and machine learning\n## Single-cell RNA sequencing and communication analysis\n## Prognostic modeling and validation\n## Functional and drug-response assays\n# Results\n# Conclusions","[{\"question\":\"What is the study’s main goal?\",\"answer\":\"The study characterizes RNA modification enzymes using integrative multi-omics and identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma.\"},{\"question\":\"How were prognostic and diagnostic models developed and validated?\",\"answer\":\"A LASSO-derived prognostic model was trained and validated in independent cohorts, and the work integrates a 6-gene prognostic model into a calibrated nomogram.\"},{\"question\":\"What did single-cell analyses reveal about the selected RMEs?\",\"answer\":\"Single-cell transcriptomic analysis showed that most selected RMEs, including NAT10, are enriched in tumor-infiltrating cells, and specific T-cell subpopulations display distinct RME expression patterns.\"},{\"question\":\"What functional evidence supports NAT10 in hepatocellular carcinoma?\",\"answer\":\"NAT10 knockdown in HCC cells reduced proliferative activity validated by qRT-PCR and EdU assays, and immunohistochemistry supported NAT10 overexpression in clinical tumor specimens versus adjacent normal tissues.\"}]","Multi-omics characterization of RNA modification enzymes identifies NAT10 as a functionally validated prognostic biomarker in hepatocellular carcinoma | PDF",1790085969,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e1973d2d7a8022b5b30e0cf4e45bf2f.webp",983,1389,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee5af8b4064504abeb597d4ffae37563.webp",982,1388,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/248d51efbc84d6ac5c84c2ad72cce3ac.webp",981,1386,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4867bde8388d75ac8bb205723990bfe.webp",980,1385]